People living with CML need a lot of information so they can make informed decisions about their health and the medications they take.
Montreal, QC (PRWEB) April 29, 2014
Every day in North America, about 16 people are diagnosed with a form of blood cancer called chronic myelogenous leukemia (CML). This disease is characterized by an abnormal proliferation of white blood cells, which results in bruising, a swollen spleen and bleeding complications. Until recently, life expectancy was only a few years for people diagnosed with CML.
That picture changed a decade ago with the development of new medications that target the underlying genetic mutation that causes CML. These medications have transformed CML into a chronic – rather than fatal – illness. With prompt, effective treatment, most people with CML no longer die of their disease.
“People living with CML need a lot of information so they can make informed decisions about their health and the medications they take,” says Anne St-Michel, publisher of CML-IQ, a new online information service for people affected by CML. “That information is changing all the time. Thousands of research studies are published every year, and new medications are providing people with more and more options. Our goal, with this new site, is to provide people with accurate, up-to-date information so they can make more informed decisions about their care.”
CML-IQ (http://cml-iq.com/) is a free information service offering the latest research news on CML, tips on living with the disease, and practical advice to help in making decisions. Launched in April 2014, the website offers in-depth articles about drug studies, background pieces that explain the disease, and tips on how to manage troublesome symptoms. CML-IQ also plans to attend the top leukemia meetings throughout the year to provide up-to-the-minute reports on the latest developments in leukemia research.
“Our approach will be to provide the facts, summarize the research, and explain the new ideas about emerging treatments,” says Steven Manners, Editor. “Our hope is to encourage people to have more meaningful discussions with their doctors and nurses. People need to be well-informed so they make the best choices about managing their CML.”
CML-IQ is a free information service for people whose lives have been affected by chronic myelogenous leukemia. Its goal is to provide people with timely, accurate news and information about CML to enable people to understand the disease and make informed choices. Visit CML-IQ a http://cml-iq.com.